Norverapamil  

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:100mg in glass bottle
产品描述:基本信息 产品编号: N11022 产品名称: Norverapamil CAS: 67018-85-3   储存条件 粉末 -20℃ 四年 分子式: C26H36N2O4 溶于液体 -80℃ 一年 分子量: 440.58     化学名:  Benzeneacetonitrile,a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-a-(1-methylethyl)- Solubility (25°C):   体外:   DMSO   Ethanol   Water   体内(现配现用):   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   生物活性 产品描述 Verapamil的N-去甲基代谢物,是一种钙通道(L-typecalciumchannel)阻滞剂和P-糖蛋白(P-gp)功能抑制剂。 靶点 Calcium channel blocker P-glycoprotein (P-gp) inhibitor   体外研究 Norverapamil ((±)-Norverapamil) is similarly effective as verapamil at inhibiting isoniazid and rifampicin tolerance and killing of intracellular M.tuberculosis in the absence of other drugs.norverapamil,also inhibits macrophage-induced tolerance and achieves similar serum levels to verapamil.Verapamil and its major metabolite Norverapamil were identified to be both mechanism-based inhibitors and substrates of CYP3A and reported to have non-linear pharmacokinetics in clinic. 体内研究 Norverapamil (9mg/kg;p.o.),a major metabolite of verapamil,has terminal half-life,AUC and Cmax values of 9.4 hours,260ng▪h/ml,and 41.6ng/mL,respectively. Animal Model: Male Sprague-Dawley rats Dosage: 9mg/kg (Pharmacokinetic Study) Administration: Oral administration Result: t1/2=9.4 hours;AUC=260ng▪h/mL;Cmax=41.6ng/mL.
保存条件:-20℃